Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03579771
Recruitment Status : Recruiting
First Posted : July 9, 2018
Last Update Posted : March 8, 2019
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
Shishir Kumar Maithel, Emory University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 30, 2021
  Estimated Study Completion Date : September 30, 2024